Convatec's New CFO Well Aligned With Company Strategy -- Market Talk

0825 GMT - Convatec's appointment of Jill McConnell as its new finance chief provides an orderly transition following the previously announced departure of Fiona Ryder, Bernstein's analysts write. McConnell has more than 25 years of finance leadership experience across healthcare and life sciences, especially in the U.S., according to the global medical products and technologies company. "Ms. McConnell's combination of public-company CFO experience, healthcare expertise and significant U.S. exposure appears well aligned with Convatec's current priorities and the next phase of its Accelerate strategy," the analysts say. Bernstein has an outperform rating on the stock and 280 pence target price. Shares are down 1.7% at 241.40 pence. (ian.walker@wsj.com)

(END) Dow Jones Newswires

November 03, 2026 03:25 ET (08:25 GMT)